Sign in
4

Changes in Ownership

Nuvation Bio Inc. Filed Acc 0001415889-24-022940

CEO, ANHEART THERAPEUTICS LTD. acquired 4,239,300 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Wang Junyuan Jerry · CEO, ANHEART THERAPEUTICS LTD.

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2024-09-04 Conversion : show line 1 in the form +2,543,600 3,922,589 D
2024-09-04 Conversion : show line 2 in the form +1,695,700 2,246,458 I

Table II: Derivative

6 lines
Date Transaction Shares Owned after D/I
2024-09-03 Grant or award : show line 3 in the form Series A Preferred Stock +25,436 25,436 D
2024-09-03 Grant or award : show line 4 in the form Series A Preferred Stock +16,957 16,957 I
2024-09-03 Grant or award : show line 5 in the form Warrants (Right to Buy) +86,471 86,471 D
2024-09-03 Grant or award : show line 6 in the form Warrants (Right to Buy) +57,647 57,647 I
2024-09-04 Conversion : show line 7 in the form Series A Preferred Stock −25,436 0 D
2024-09-04 Conversion : show line 8 in the form Series A Preferred Stock −16,957 0 I
Loading xslF345X05/form4-09052024_080952.xml…